1,869
Views
5
CrossRef citations to date
0
Altmetric
Research Article

ALSUntangled No. 47: RT001

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Richard Bedlack, Sky Kihuwa-mani, Paul E. Barkhaus, Michael Bereman, James B. Caress, Jesse Crayle, Gary L. Pattee, Terry Heiman Patterson, Paul Wicks, Neta Zach, Gregory T. Carter & Kristiana Salmon. (2021) ALSUntangled 59: Tamoxifen. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 595-598.
Read now
. (2021) ALSUntangled 57: Vinpocetine. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 316-319.
Read now
Bedlack Richard. (2021) ALSUntangled 55: vitamin E (α-tocopherol). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:1-2, pages 154-160.
Read now

Articles from other publishers (2)

Xiao-Liang Xu, Wen Zhang & Guo-Wu Rao. (2023) Clinical Application and Synthesis Methods of Deuterated Drugs. Current Medicinal Chemistry 30:36, pages 4096-4129.
Crossref
David R. Lynch, Katherine D. Mathews, Susan Perlman, Theresa Zesiewicz, Sub Subramony, Omid Omidvar, Adam P. Vogel, Ana Krtolica, Nadia Litterman, Lex van der Ploeg, Frederic Heerinckx, Peter Milner & Mark Midei. (2022) Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia. Journal of Neurology 270:3, pages 1615-1623.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.